US Broker Ratings

XOMA Royalty Corporation (XOMA) Stock Analysis: Unpacking a 152% Potential Upside

XOMA Royalty Corporation (NASDAQ: XOMA), a key player in the biotechnology sector, presents a compelling opportunity for investors with its impressive 152.11% potential upside, as suggested by analyst target prices...

Spok Holdings, Inc. (SPOK) Stock Analysis: Solid Dividend Yield and 17.44% Potential Upside

For investors seeking opportunities in the healthcare sector, Spok Holdings, Inc. (NASDAQ: SPOK) presents a compelling case with its robust dividend yield and notable potential upside. Specializing in health information..

TruBridge, Inc. (TBRG) Stock Analysis: Unpacking a 39.55% Potential Upside for Investors in Healthcare Tech

TruBridge, Inc. (NASDAQ: TBRG) is capturing the attention of investors with a compelling blend of innovative healthcare solutions and a substantial potential upside. With a market capitalization of $314.89 million,..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring a 216% Potential Upside in the CGM Market

Senseonics Holdings, Inc. (NYSEAMERICAN: SENS) is making waves in the healthcare sector with its innovative approach to continuous glucose monitoring (CGM) systems. Based in Germantown, Maryland, this commercial-stage medical device..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Exploring a 128.57% Potential Upside

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology firm, is drawing considerable attention for its innovative approach to genetic medicine. Headquartered in Hayward, California, Benitec is establishing itself as a..

10x Genomics, Inc. (TXG) Investor Outlook: Navigating Uncertain Valuations with Strategic Insights

10x Genomics, Inc. (NASDAQ: TXG), a pioneering force in the healthcare sector, continues to captivate investors with its cutting-edge technology in health information services. Headquartered in Pleasanton, California, the company..

BioLife Solutions, Inc. (BLFS)

❌ Error generating article: Server error: `POST https://api.openai.com/v1/chat/completions` resulted in a `503 Service Unavailable` response: upstream connect error or disconnect/reset before headers. reset reason: connection timeout

..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 71% Potential Upside in the Healthcare Sector

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector specializing in diagnostics and research, has captured investor attention with its significant upside potential. Operating a network of cancer-focused..

Artivion, Inc. (AORT) Stock Analysis: Unpacking the 4.49% Potential Upside in Healthcare Innovation

Artivion, Inc. (NASDAQ: AORT) is making waves in the healthcare sector with its innovative approach to medical devices and implantable human tissues. Headquartered in Kennesaw, Georgia, the company is a..

AdaptHealth Corp. (AHCO) Investor Outlook: Analyzing a 34.25% Potential Upside

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector, operates within the medical devices industry, specializing in the distribution of home medical equipment and supplies across the United..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring 26% Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG), a prominent player in the medical care facilities industry, is attracting attention from investors with its potential upside of 26.42%. As of now, the..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 195% Upside Amidst Challenging Financials

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, operates in the diagnostics and pharmaceuticals industries, catering to a diverse market spanning the United States, Europe, and..

Pulse Biosciences, Inc (PLSE): Investor Outlook with a 44.64% Potential Upside

Pulse Biosciences, Inc. (NASDAQ: PLSE), a burgeoning entity in the healthcare sector, is making waves with its innovative approach to medical instruments and supplies. With a market capitalization of $1.02..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Uncovering a Potential 148% Upside in Biotech Innovation

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology company, is making waves in the healthcare sector with its cutting-edge RNA medicines platform, PRISM. Despite recent challenges, the company’s innovative..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Unveiling a 106% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a dynamic player in the healthcare sector, is making waves in the biopharmaceutical landscape with its promising vaccine portfolio. Headquartered in Emeryville, California, Dynavax is..

Indivior PLC (INDV) Stock Analysis: Evaluating Growth Potential with a 11.18% Upside

Indivior PLC (INDV), a prominent player in the healthcare sector, specializing in drug manufacturing, particularly in the realm of opioid dependence treatment, presents an intriguing opportunity for investors. With its..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Unveiling a 40% Upside Potential

U.S. Physical Therapy, Inc. (NYSE: USPH) is gaining traction among investors, buoyed by a promising 40.71% potential upside according to analyst consensus. This Houston-based company, specializing in outpatient physical therapy..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: 12.49% Potential Upside Captivates Investors

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biotechnology firm focused on autoimmune diseases, presents a compelling opportunity for investors with its innovative therapies and promising financial metrics. As of the..

Evolent Health (EVH) Stock Analysis: Exploring a 58% Upside Potential Amidst Healthcare Sector Challenges

Evolent Health, Inc (NYSE: EVH) stands as a key player in the health information services industry, offering an integrated platform for health plan administration and value-based business infrastructure. With its..

Phreesia, Inc. (PHR) Stock Analysis: A 18.74% Potential Upside in the Health Information Services Sector

Phreesia, Inc. (NYSE: PHR) is garnering the attention of investors with its promising 18.74% potential upside, according to analyst ratings. As a key player in the healthcare sector’s information services..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds